DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.66−0.01 (-0.10%)
Close on Nov 11, 2026Market cap $520.92MP/E –Yield –
DiaMedica Therapeutics cash
Cash and short-term investments held at the end of each period.
DiaMedica Therapeutics's cash was $34.90M at Sep 30, 2026. For fiscal 2025 it was $59.90M, up 35.8% from the year before. The highest annual figure on record is $59.90M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $59.90M | +35.8% |
| FY2024 | Dec 31, 2024 | $44.10M | -16.6% |
| FY2023 | Dec 31, 2023 | $52.90M | +57.9% |
| FY2022 | Dec 31, 2022 | $33.50M | -25.7% |
| FY2021 | Dec 31, 2021 | $45.11M | +64.0% |
| FY2020 | Dec 31, 2020 | $27.51M | +248.2% |
| FY2019 | Dec 31, 2019 | $7.90M | -53.0% |
| FY2018 | Dec 31, 2018 | $16.82M | +1143.4% |
| FY2017 | Dec 31, 2017 | $1.35M | -22.1% |
| FY2016 | Dec 31, 2016 | $1.74M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $34.90M | -36.9% |
| Q2 FY2026 | Jun 30, 2026 | $43.50M | +45.0% |
| Q1 FY2026 | Mar 31, 2026 | $51.30M | +37.5% |
| Q4 FY2025 | Dec 31, 2025 | $59.90M | +35.8% |
| Q3 FY2025 | Sep 30, 2025 | $55.30M | +10.2% |
| Q2 FY2025 | Jun 30, 2025 | $30.00M | -44.5% |
| Q1 FY2025 | Mar 31, 2025 | $37.30M | -19.8% |
| Q4 FY2024 | Dec 31, 2024 | $44.10M | -16.6% |
| Q3 FY2024 | Sep 30, 2024 | $50.20M | -10.7% |
| Q2 FY2024 | Jun 30, 2024 | $54.10M | -10.9% |
| Q1 FY2024 | Mar 31, 2024 | $46.50M | +62.0% |
| Q4 FY2023 | Dec 31, 2023 | $52.90M | +57.9% |
| Q3 FY2023 | Sep 30, 2023 | $56.20M | +55.7% |
| Q2 FY2023 | Jun 30, 2023 | $60.70M | +58.1% |
| Q1 FY2023 | Mar 31, 2023 | $28.70M | -30.1% |
| Q4 FY2022 | Dec 31, 2022 | $33.50M | -25.7% |
| Q3 FY2022 | Sep 30, 2022 | $36.10M | +122.8% |
| Q2 FY2022 | Jun 30, 2022 | $38.40M | +1645.5% |
| Q1 FY2022 | Mar 31, 2022 | $41.05M | +1143.8% |
| Q4 FY2021 | Dec 31, 2021 | $45.11M | +64.0% |
| Q3 FY2021 | Sep 30, 2021 | $16.20M | +65.3% |
| Q2 FY2021 | Jun 30, 2021 | $2.20M | -56.0% |
| Q1 FY2021 | Mar 31, 2021 | $3.30M | 0.0% |
| Q4 FY2020 | Dec 31, 2020 | $27.51M | +248.2% |
| Q3 FY2020 | Sep 30, 2020 | $9.80M | +0.6% |
| Q2 FY2020 | Jun 30, 2020 | $5.00M | -54.4% |
| Q1 FY2020 | Mar 31, 2020 | $3.30M | -75.9% |
| Q4 FY2019 | Dec 31, 2019 | $7.90M | -53.0% |
| Q3 FY2019 | Sep 30, 2019 | $9.74M | +149.9% |
| Q2 FY2019 | Jun 30, 2019 | $10.97M | +91.5% |
| Q1 FY2019 | Mar 31, 2019 | $13.72M | +104.4% |
| Q4 FY2018 | Dec 31, 2018 | $16.82M | +1143.4% |
| Q3 FY2018 | Sep 30, 2018 | $3.90M | +124.5% |
| Q2 FY2018 | Jun 30, 2018 | $5.73M | – |
| Q1 FY2018 | Mar 31, 2018 | $6.71M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.35M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.74M | – |
See a number that looks wrong?